| Michael Keith Jacobs, MD | |
|
3918 Montclair Rd, Suite 105, Mountain Brk, AL 35213-2425 | |
| (205) 705-3550 | |
| (205) 705-3554 |
| Full Name | Michael Keith Jacobs |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 23 Years |
| Location | 3918 Montclair Rd, Mountain Brk, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134157597 | NPI | - | NPPES |
| 51136288 | Other | AL | BLUE CROSS |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Pathologists Llc | 0648167544 | 103 |
News Archive
A team of researchers at the Institute of Infectious Diseases (IFIK) at the University of Bern and the Institute of Virology and Immunology (IVI) has utilized a unique collection of advanced cell culture models of cells lining the airways from various domesticated and wildlife animals. This way, the team can determine which animals are susceptible to SARS-CoV-2 infection.
The measure, which Medicaid advocates say would "devastate the program," would repeal the maintenance of effort provision in the health law which prevents states from cutting eligibility rules before 2014. GOP backers argue it is the best way to give states more flexibility to deal with the program as they face budget shortfalls.
Compugen Ltd. announced today the signing of a collaboration and license agreement for the research, development, and commercialization of antibody-based therapeutics for cancer immunotherapy against two novel Compugen discovered immune checkpoint regulators.
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
However, in other research, white blood cells' exact roles and subtypes in severe COVID-19 are still unclear. The team writes, "It is unknown if blood cell counts before infection are associated with the risk of developing severe COVID-19." They explained that the numbers of these cell types could be influenced by several factors such as age, gender, disease status, and medications.
› Verified 3 days ago
| Entity Name | Dermlab Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164764528 PECOS PAC ID: 7810137213 Enrollment ID: O20130709000727 |
News Archive
A team of researchers at the Institute of Infectious Diseases (IFIK) at the University of Bern and the Institute of Virology and Immunology (IVI) has utilized a unique collection of advanced cell culture models of cells lining the airways from various domesticated and wildlife animals. This way, the team can determine which animals are susceptible to SARS-CoV-2 infection.
The measure, which Medicaid advocates say would "devastate the program," would repeal the maintenance of effort provision in the health law which prevents states from cutting eligibility rules before 2014. GOP backers argue it is the best way to give states more flexibility to deal with the program as they face budget shortfalls.
Compugen Ltd. announced today the signing of a collaboration and license agreement for the research, development, and commercialization of antibody-based therapeutics for cancer immunotherapy against two novel Compugen discovered immune checkpoint regulators.
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
However, in other research, white blood cells' exact roles and subtypes in severe COVID-19 are still unclear. The team writes, "It is unknown if blood cell counts before infection are associated with the risk of developing severe COVID-19." They explained that the numbers of these cell types could be influenced by several factors such as age, gender, disease status, and medications.
› Verified 3 days ago
| Entity Name | Associated Pathologists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003863580 PECOS PAC ID: 0648167544 Enrollment ID: O20210521000436 |
News Archive
A team of researchers at the Institute of Infectious Diseases (IFIK) at the University of Bern and the Institute of Virology and Immunology (IVI) has utilized a unique collection of advanced cell culture models of cells lining the airways from various domesticated and wildlife animals. This way, the team can determine which animals are susceptible to SARS-CoV-2 infection.
The measure, which Medicaid advocates say would "devastate the program," would repeal the maintenance of effort provision in the health law which prevents states from cutting eligibility rules before 2014. GOP backers argue it is the best way to give states more flexibility to deal with the program as they face budget shortfalls.
Compugen Ltd. announced today the signing of a collaboration and license agreement for the research, development, and commercialization of antibody-based therapeutics for cancer immunotherapy against two novel Compugen discovered immune checkpoint regulators.
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
However, in other research, white blood cells' exact roles and subtypes in severe COVID-19 are still unclear. The team writes, "It is unknown if blood cell counts before infection are associated with the risk of developing severe COVID-19." They explained that the numbers of these cell types could be influenced by several factors such as age, gender, disease status, and medications.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Keith Jacobs, MD 1010 Airpark Center Dr, Nashville, TN 37217-5200 Ph: (615) 221-4400 | Michael Keith Jacobs, MD 3918 Montclair Rd, Suite 105, Mountain Brk, AL 35213-2425 Ph: (205) 705-3550 |
News Archive
A team of researchers at the Institute of Infectious Diseases (IFIK) at the University of Bern and the Institute of Virology and Immunology (IVI) has utilized a unique collection of advanced cell culture models of cells lining the airways from various domesticated and wildlife animals. This way, the team can determine which animals are susceptible to SARS-CoV-2 infection.
The measure, which Medicaid advocates say would "devastate the program," would repeal the maintenance of effort provision in the health law which prevents states from cutting eligibility rules before 2014. GOP backers argue it is the best way to give states more flexibility to deal with the program as they face budget shortfalls.
Compugen Ltd. announced today the signing of a collaboration and license agreement for the research, development, and commercialization of antibody-based therapeutics for cancer immunotherapy against two novel Compugen discovered immune checkpoint regulators.
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
However, in other research, white blood cells' exact roles and subtypes in severe COVID-19 are still unclear. The team writes, "It is unknown if blood cell counts before infection are associated with the risk of developing severe COVID-19." They explained that the numbers of these cell types could be influenced by several factors such as age, gender, disease status, and medications.
› Verified 3 days ago
Dr. Jenny Oakes Sobera, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2900 Cahaba Rd, Mountain Brk, AL 35223 Phone: 205-877-9773 Fax: 205-877-9775 | |
Dr. Charles Andrew Parrish, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3918 Montclair Rd, Suite 105, Mountain Brk, AL 35213 Phone: 205-705-3550 Fax: 205-705-3554 | |
Julia Tauscher, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2900 Cahaba Rd, Mountain Brk, AL 35223 Phone: 205-877-9773 Fax: 205-877-9775 | |
Caroline Crabtree, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2900 Cahaba Rd, Mountain Brk, AL 35223 Phone: 205-877-9773 Fax: 205-877-9775 | |
Stephen E. Mason, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3918 Montclair Rd, Suite 105, Mountain Brk, AL 35213 Phone: 205-705-3550 Fax: 205-705-3554 | |
Dr. Rachel Teat Pflederer, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2900 Cahaba Rd, Mountain Brk, AL 35223 Phone: 205-877-9773 Fax: 205-877-9775 |